Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4

Stefano Omboni, Claudio Borghi, Ambrosioni, Cicero, Stefano Bacchelli, Daniela Degli Esposti, Novo, Dragos Vinereanu, Giuseppe Ambrosio, Reggiardo, Zava
  • ClinicoEconomics and Outcomes Research, July 2013, Dove Medical Press
  • DOI: 10.2147/ceor.s43138
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
open access logoRead Publication

The following have contributed to this page: Stefano Omboni, Dr Arrigo FG CICERO, and Professor Giuseppe Ambrosio